Pharmafile Logo
Pharmafocus logo
Advanced Search

ABPI sets up links to clinical trials databases

July 7, 2005
Sales and Marketing

Website links to details of more than 4,000 clinical trials have been published by the ABPI, as the global agreement …

News

Pfizer pulls out of Daxas collaboration

July 7, 2005
Sales and Marketing Daxas, Nycomed, Pfizer

Pfizer has pulled out of an agreement with Altana Pharma to develop and market a new treatment for asthma and …

News

One Europe for pharma marketers?

July 6, 2005
Sales and Marketing

Pharma economists will tell you that the world has a market 'top three'. The US is way ahead in the …

Feature

No more Alton Towers? UK pharma downsizes its hospitality

July 6, 2005
Sales and Marketing

UK-based pharmaceutical companies have pre-empted strict new European rules on entertaining healthcare professionals by imposing their own restrictions.The companies are …

News

‘Ticking time bomb’ will go off as NHS investment slows

July 6, 2005

News

Lilly buys rights to novel diabetes drug

July 6, 2005
Research and Development, Sales and Marketing

Eli Lilly has signed a licensing agreement with Japanese pharmaceutical company Taisho for TS-021, a novel treatment for type II …

News

Orphans join European pharma family

July 5, 2005
Sales and Marketing

Feature

Antidepressants come under FDA review again

July 4, 2005
Sales and Marketing

The FDA is conducting another review of antidepressants to determine whether the drugs increase the risk of suicidal behaviour in …

News

GSK excited about new vaccines

July 4, 2005
Sales and Marketing

GlaxoSmithKline has updated investors on its vaccine pipeline, with the company expecting to launch five major vaccines within as many …

News

Doctors have no time to mentor nurse prescribers

June 30, 2005

Doctors have expressed concern that they do not have time to act as mentors to independent nurse prescribers, according to …

News

NHS to save

June 30, 2005

News

Bright future for new antidepressants

June 30, 2005
Research and Development, Sales and Marketing

News

The golden rules of PR

June 29, 2005
Medical Communications

In light of the enormous potential brand benefits of pharma PR,  the question should not be 'Shall we invest in …

Feature

Humira receives two European recommendations

June 29, 2005
Sales and Marketing

Abbott's Humira has moved closer to European approval as a first-line treatment of moderate to severe early rheumatoid arthritis in …

News

All aboard the health train

June 29, 2005
Medical Communications

Making friends and influencing people is an area, it's widely agreed, where big pharma could do better. Few companies, however, …

Feature

New products key to Schering growth

June 29, 2005
Sales and Marketing

Schering has reiterated its goal of achieving an 18% operating margin in 2006 and is predicting further growth in the …

News

FDA approves new HIV drug Aptivus

June 29, 2005
Sales and Marketing

Boehringer Ingelheim's new HIV drug Aptivus has been granted accelerated approval by the FDA. Aptivus (tipranavir) has been approved for …

News

GSK forms hypertension alliance

June 29, 2005
Sales and Marketing

GlaxoSmithKline has formed a strategic alliance with an emerging pharma company to develop and commercialise novel compounds to treat hypertension …

News

FDA approves first ‘ethnic’ heart drug

June 29, 2005
Research and Development, Sales and Marketing

The FDA has approved BiDil as a new treatment for heart failure in black patients, a group disproportionately affected by …

News

Woolley Pau wins Chiron campaign

June 29, 2005
Medical Communications

Woolley Pau has been appointed by Chiron Biopharma Europe to work on a pan-European launch campaign, following a four-way pitch.A …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025